Cargando…

Klotho as a biomarker of subclinical atherosclerosis in patients with moderate to severe chronic kidney disease

Chronic kidney disease (CKD) has been associated with a higher risk of cardiovascular disease (CVD). CKD patients present a decrease in the levels of the protein Klotho that accompanies the decrease in kidney function. This protein has been related to protective effects against CVD. However, it is u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Donate-Correa, Javier, Ferri, Carla M., Martín-Núñez, Ernesto, Pérez-Delgado, Nayra, González-Luis, Ainhoa, Mora-Fernández, Carmen, Navarro-González, Juan F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342510/ https://www.ncbi.nlm.nih.gov/pubmed/34354161 http://dx.doi.org/10.1038/s41598-021-95488-4

Ejemplares similares

Association of Klotho with Coronary Artery Disease in Subjects with Type 2 Diabetes Mellitus and Preserved Kidney Function: A Case-Control Study
por: Donate-Correa, Javier, et al.
Publicado: (2023)

Influence of Klotho gene polymorphisms on vascular gene expression and its relationship to cardiovascular disease
por: Donate‐Correa, Javier, et al.
Publicado: (2015)

Association between serum levels of Klotho and inflammatory cytokines in cardiovascular disease: a case-control study
por: Martín-Núñez, Ernesto, et al.
Publicado: (2020)

Klotho, Oxidative Stress, and Mitochondrial Damage in Kidney Disease
por: Donate-Correa, Javier, et al.
Publicado: (2023)

Klotho inversely relates with carotid intima- media thickness in atherosclerotic patients with normal renal function (eGFR ≥60 mL/min/1.73m(2)): a proof-of-concept study
por: Donate-Correa, Javier, et al.
Publicado: (2023)

FGF23 and Klotho Levels are Independently Associated with Diabetic Foot Syndrome in Type 2 Diabetes Mellitus
por: Donate-Correa, Javier, et al.
Publicado: (2019)

Klotho expression in peripheral blood circulating cells is associated with vascular and systemic inflammation in atherosclerotic vascular disease
por: Martín-Núñez, Ernesto, et al.
Publicado: (2022)

Inflammatory Cytokines in Diabetic Kidney Disease: Pathophysiologic and Therapeutic Implications
por: Donate-Correa, Javier, et al.
Publicado: (2021)

Pathophysiological Implications of Imbalances in Fibroblast Growth Factor 23 in the Development of Diabetes
por: Donate-Correa, Javier, et al.
Publicado: (2021)

Repurposing drugs for highly prevalent diseases: pentoxifylline, an old drug and a new opportunity for diabetic kidney disease
por: Donate-Correa, Javier, et al.
Publicado: (2022)

Extracellular water/total body water ratio as predictor of mortality in hemodialysis patients
por: Pérez-Morales, Rosa, et al.
Publicado: (2021)

Associations between Inflammation, Hemoglobin Levels, and Coronary Artery Disease in Non-Albuminuric Subjects with and without Type 2 Diabetes Mellitus
por: Donate-Correa, Javier, et al.
Publicado: (2023)

Pentoxifylline for Renal Protection in Diabetic Kidney Disease. A Model of Old Drugs for New Horizons
por: Donate-Correa, Javier, et al.
Publicado: (2019)

Association of α-klotho with subclinical carotid atherosclerosis in subjects with type 1 diabetes mellitus
por: Castelblanco, Esmeralda, et al.
Publicado: (2022)

Inflammatory Cytokines in Diabetic Nephropathy
por: Donate-Correa, Javier, et al.
Publicado: (2015)

A Novel Heterozygous Deletion Variant in KLOTHO Gene Leading to Haploinsufficiency and Impairment of Fibroblast Growth Factor 23 Signaling Pathway
por: Martín-Núñez, Ernesto, et al.
Publicado: (2019)

Inflammatory Targets in Diabetic Nephropathy
por: Donate-Correa, Javier, et al.
Publicado: (2020)

Fibroblast growth factor 23 expression in human calcified vascular tissues
por: Donate-Correa, Javier, et al.
Publicado: (2019)

The incidence of subclinical atherosclerosis in subjects with low and moderate cardiovascular risk
por: Li, Yan, et al.
Publicado: (2023)

Skin Autofluorescence and Subclinical Atherosclerosis in Mild to Moderate Chronic Kidney Disease: A Case-Control Study
por: Sánchez, Enric, et al.
Publicado: (2017)

Role of Klotho and AGE/RAGE-Wnt/β-Catenin Signalling Pathway on the Development of Cardiac and Renal Fibrosis in Diabetes
por: Martín-Carro, Beatriz, et al.
Publicado: (2023)

Serum and Urinary Soluble α-Klotho as Markers of Kidney and Vascular Impairment
por: Martín-Vírgala, Julia, et al.
Publicado: (2023)

Association of High-Density Lipoprotein Subclasses with Chronic Kidney Disease Progression, Atherosclerosis, and Klotho
por: Kanda, Eiichiro, et al.
Publicado: (2016)

Primary Sjögren's syndrome as independent risk factor for subclinical atherosclerosis
por: Novella-Navarro, Marta, et al.
Publicado: (2022)

Influence of coronary artery disease and subclinical atherosclerosis related polymorphisms on the risk of atherosclerosis in rheumatoid arthritis
por: López-Mejías, Raquel, et al.
Publicado: (2017)

Biomarkers of subclinical atherosclerosis in patients with psoriasis
por: Kaiser, Hannah, et al.
Publicado: (2021)

Kidney Function and Subclinical Arrhythmias: The Multi-Ethnic Study of Atherosclerosis
por: Wiggins, Kerri L., et al.
Publicado: (2021)

A Nomogram for Identifying Subclinical Atherosclerosis in Chronic Kidney Disease
por: Xiong, Jiachuan, et al.
Publicado: (2021)

Klotho, Aging, and the Failing Kidney
por: Buchanan, Sarah, et al.
Publicado: (2020)

SUBCLINICAL KIDNEY INJURY IS CAUSED BY A MODERATE SINGLE INFLAMMATORY EVENT
por: Heinzl, Matthias Wolfgang, et al.
Publicado: (2022)

Relationship of Blood Inflammatory Composite Markers with Cardiovascular Risk Factors and Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis
por: González-Sierra, Marta, et al.
Publicado: (2023)

Associations of kidney injury markers with subclinical cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis
por: Park, Meyeon, et al.
Publicado: (2015)

Biomarkers of Subclinical Atherosclerosis in Patients with Autoimmune Disorders
por: Profumo, Elisabetta, et al.
Publicado: (2012)

Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis
por: Peluso, Rosario, et al.
Publicado: (2019)

Evaluation of endothelial function and subclinical atherosclerosis in patients with HIV infection
por: Arnaiz de las Revillas, F., et al.
Publicado: (2021)

Subclinical atherosclerosis in patients with psoriasis
por: Balta, Ilknur, et al.
Publicado: (2015)

Diabetes and Subclinical Coronary Atherosclerosis
por: Lee, Chang Hoon, et al.
Publicado: (2018)

Predictors of subclinical atherosclerosis in HIV
por: Fernández Soto, Julia, et al.
Publicado: (2023)

Selective Vitamin D Receptor Activation as Anti-Inflammatory Target in Chronic Kidney Disease
por: Donate-Correa, J., et al.
Publicado: (2014)

Unbiased plasma proteomics discovery of biomarkers for improved detection of subclinical atherosclerosis
por: Núñez, Estefanía, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g3egmtjkdhvcko2inpis41k6kv